Zotepine in levodopa-induced Psychosis.
Spieker
S
S
Department of Neurology, University of Tübingen, Germany.
Stetter
F
F
Klockgether
T
T
D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003988:Dibenzothiepins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced / Q000188:drug therapy* / Q000209:etiology
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D003988:Dibenzothiepins; D007980:Levodopa; C022172:zotepine